PL2916856T3 - Zastosowania bremelanotydu w leczeniu dysfunkcji seksualnej u kobiet - Google Patents

Zastosowania bremelanotydu w leczeniu dysfunkcji seksualnej u kobiet

Info

Publication number
PL2916856T3
PL2916856T3 PL13851014T PL13851014T PL2916856T3 PL 2916856 T3 PL2916856 T3 PL 2916856T3 PL 13851014 T PL13851014 T PL 13851014T PL 13851014 T PL13851014 T PL 13851014T PL 2916856 T3 PL2916856 T3 PL 2916856T3
Authority
PL
Poland
Prior art keywords
bremelanotide
therapy
sexual dysfunction
female sexual
female
Prior art date
Application number
PL13851014T
Other languages
English (en)
Other versions
PL2916856T5 (pl
Inventor
Carl Spana
Robert Jordan
Jeffrey D. Edelson
Original Assignee
Palatin Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50628268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2916856(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Palatin Technologies, Inc. filed Critical Palatin Technologies, Inc.
Publication of PL2916856T3 publication Critical patent/PL2916856T3/pl
Publication of PL2916856T5 publication Critical patent/PL2916856T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
PL13851014.4T 2012-11-05 2013-11-05 Zastosowania bremelanotydu w leczeniu dysfunkcji seksualnej u kobiet PL2916856T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261722511P 2012-11-05 2012-11-05
US201361770535P 2013-02-28 2013-02-28
EP13851014.4A EP2916856B2 (en) 2012-11-05 2013-11-05 Uses of bremelanotide in therapy for female sexual dysfunction
PCT/US2013/068386 WO2014071339A2 (en) 2012-11-05 2013-11-05 Uses of bremelanotide in therapy for female sexual dysfunction

Publications (2)

Publication Number Publication Date
PL2916856T3 true PL2916856T3 (pl) 2019-02-28
PL2916856T5 PL2916856T5 (pl) 2024-01-29

Family

ID=50628268

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13851014.4T PL2916856T5 (pl) 2012-11-05 2013-11-05 Zastosowania bremelanotydu w leczeniu dysfunkcji seksualnej u kobiet

Country Status (24)

Country Link
US (7) US9352013B2 (pl)
EP (1) EP2916856B2 (pl)
JP (1) JP6567971B2 (pl)
KR (1) KR102253526B1 (pl)
CN (2) CN104755094A (pl)
AU (1) AU2013337341B2 (pl)
BR (1) BR112015009936A8 (pl)
CA (1) CA2890081A1 (pl)
DK (1) DK2916856T4 (pl)
EA (1) EA032959B9 (pl)
ES (1) ES2701444T5 (pl)
FI (1) FI2916856T4 (pl)
GE (1) GEP20196947B (pl)
HK (1) HK1211227A1 (pl)
IL (1) IL238276B (pl)
MX (1) MX362610B (pl)
MY (1) MY179755A (pl)
NZ (1) NZ707246A (pl)
PH (1) PH12015500915A1 (pl)
PL (1) PL2916856T5 (pl)
SG (1) SG11201502949QA (pl)
UA (1) UA118656C2 (pl)
WO (1) WO2014071339A2 (pl)
ZA (1) ZA201503128B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590209B2 (en) * 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235625B2 (en) * 1999-06-29 2007-06-26 Palatin Technologies, Inc. Multiple agent therapy for sexual dysfunction
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
US7176279B2 (en) 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
US7022674B2 (en) 1999-12-16 2006-04-04 Eli Lilly And Company Polypeptide compositions with improved stability
DE60112440T2 (de) * 2000-05-31 2006-04-20 Novo Nordisk A/S Wegwerfbare zweispitzige injektionsnadel
CA2453515A1 (en) 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
BRPI0518961A2 (pt) * 2004-12-09 2008-12-16 West Pharm Serv Inc acoplamento para dispositivo de injeÇço automÁtica
WO2009120656A1 (en) * 2008-03-24 2009-10-01 Palatin Technologies, Inc. Pharmaceutical for ocular indications
EA018630B1 (ru) * 2008-06-09 2013-09-30 Палатин Текнолоджиз, Инк. Специфичные к меланокортиновым рецепторам пептиды для лечения сексуальной дисфункции
WO2011060352A1 (en) * 2009-11-16 2011-05-19 Ipsen Pharma S.A.S. Pharmaceutical compositions of melanocortin receptor ligands
CN103118737B (zh) * 2010-04-21 2015-05-20 艾伯维生物技术有限公司 用于治疗药剂的受控输送的可佩戴自动注射装置

Also Published As

Publication number Publication date
PH12015500915B1 (en) 2015-06-29
CN104755094A (zh) 2015-07-01
EP2916856A4 (en) 2016-06-22
ZA201503128B (en) 2016-11-30
US10286034B2 (en) 2019-05-14
EA201590760A1 (ru) 2015-10-30
US20240335502A1 (en) 2024-10-10
EP2916856A2 (en) 2015-09-16
ES2701444T3 (es) 2019-02-22
MX2015005486A (es) 2015-11-13
JP2016503406A (ja) 2016-02-04
ES2701444T5 (es) 2024-05-21
US20190216888A1 (en) 2019-07-18
WO2014071339A2 (en) 2014-05-08
FI2916856T4 (fi) 2024-01-15
MY179755A (en) 2020-11-12
SG11201502949QA (en) 2015-06-29
NZ707246A (en) 2019-03-29
IL238276A0 (en) 2015-06-30
EP2916856B2 (en) 2023-10-18
HK1211227A1 (en) 2016-05-20
US20180085425A1 (en) 2018-03-29
US20220362328A1 (en) 2022-11-17
CN117860866A (zh) 2024-04-12
IL238276B (en) 2020-04-30
GEP20196947B (en) 2019-02-11
WO2014071339A3 (en) 2014-06-12
EP2916856B1 (en) 2018-09-19
BR112015009936A8 (pt) 2019-09-17
US9352013B2 (en) 2016-05-31
US20210060120A1 (en) 2021-03-04
JP6567971B2 (ja) 2019-08-28
US20140378392A1 (en) 2014-12-25
KR102253526B1 (ko) 2021-05-18
PL2916856T5 (pl) 2024-01-29
US9700592B2 (en) 2017-07-11
DK2916856T4 (da) 2024-01-22
DK2916856T3 (en) 2019-01-14
AU2013337341B2 (en) 2018-02-22
PH12015500915A1 (en) 2015-06-29
US20150231196A1 (en) 2015-08-20
EA032959B9 (ru) 2019-11-27
CA2890081A1 (en) 2014-05-08
UA118656C2 (uk) 2019-02-25
MX362610B (es) 2019-01-28
KR20150081345A (ko) 2015-07-13
AU2013337341A1 (en) 2015-05-07
EA032959B1 (ru) 2019-08-30
BR112015009936A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
GB2512765B (en) Devices and methods for promoting female sexual wellness
PL2726048T3 (pl) Urządzenie do stymulacji seksualnej
GB201115711D0 (en) Phyto-cannabinoids for use in the treatment of cancer
GB2495841B (en) Phytocannabinoids for use in the treatment of breast cancer
IL229474A0 (en) Cannabinoids for use in the treatment of neuropathic pain
IL232890A0 (en) Immunogenic therapy for cancer
IL230433A0 (en) Pain management methods
EP2905027A4 (en) USE OF MYCOBACTERIUM BRUMAE FOR THE TREATMENT OF BUBBLE CANCER
EP2777680A4 (en) DEVICE FOR FEMALE SEXUAL STIMULATION
EP2849712A4 (en) METHOD AND DEVICES FOR PROVIDING MECHANICAL STIMULATION TO A BODY
EP2908746A4 (en) TOOLS AND METHOD FOR THE TREATMENT OF BODY DRESSES
EP2666454A4 (en) MASTURBATION AID FOR MEN
EP2777679A4 (en) DEVICE FOR MALE SEXUAL STIMULATION
GB201309274D0 (en) Treatment Of Fuel
EP2747561A4 (en) TREATMENT OF SYMPTOMS RELATED TO FEMALE GAS TROPARESIS
PT2872176T (pt) Carboranilporpirinas para utilização no tratamento de cancro
EP2686001A4 (en) USES OF MODIFIED ELR-CXC-MODIFIED G31P CHEMOKINE FOR TREATING CANCER
EP2916856A4 (en) USE OF BREMELANOTIDE IN THE THERAPY OF FEMALE SEXUAL DYSFUNCTION
HK1209342A1 (en) A3 Adenosine Receptor Ligands For Use In Treatment Of A Sexual Dysfunction A3
EP2882419A4 (en) METHODS FOR THE TREATMENT OF CANCER USING LIPOPLATIN
GB201322958D0 (en) Uses of oligouronates in cancer treatment
TWM475277U (en) Sexual massage cup
GB201207431D0 (en) Intravaginal treatment of gynacological conditions
GB201100455D0 (en) Methods relating to treatment